At a glance
ClinicalIndex Comparison RecordN/ACompleted· 6 enrolled
Drug / intervention
Freeze-dried Blueberry Powderother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Acute Bioavailability of Berry Flavonoids and Impact on Inflammatory Biomarkers in Older Adults With Minor Depressive Symptoms: A Pilot Study
In Brief
A clinical study evaluating Freeze-dried Blueberry Powder for Depressive Symptoms and Aging. Completed, enrolled 6 participants across 1 site.
Detailed Summary
This randomized, cross-over, pilot study aims to compare preliminary impact of a standard dose of blueberry powder (24 g) vs a higher dose (48 g) on the bioavailability of flavonoids and inflammatory biomarkers in older adults with minor levels of depressive symptoms.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDepressive Symptoms, Aging
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
202420252026
First PostedJul 2023
Enrollment StartOct 2023
Primary CompletionNov 2024
TodayJul 2026
First PostedJul 10, 2023
Enrollment StartOct 31, 2023
Primary CompletionNov 25, 2024
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 3.0 years ago
Interventions
Freeze-dried Blueberry Powderother
Three day consumption of two doses of freeze-dried blueberry powder